RACHAKONDA; Sreenivas

Patent Applications and Registrations

Patent applications and USPTO patent grants for RACHAKONDA; Sreenivas.The latest application filed is for "a process for the preparation of venetoclax and its polymorphs thereof".

Company Profile

2.11.14

RACHAKONDA; Sreenivas - Banjara Hills Hyderabad
Rachakonda; Sreenivas - Hyderabad IN
Rachakonda; Sreenivas - Andhra Pradesh IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
A Process For The Preparation Of Venetoclax And Its Polymorphs Thereof App 20220259204 - SIRIGIREDDY; Balakrishna Reddy ; et al.	2022-08-18
Process for the preparation of amorphous idelalisib Grant 10,870,650 - Kompella , et al. December 22, 2	2020-12-22
Process For The Preparation Of Amorphous Idelalisib App 20200095249 - KOMPELLA; Amala ; et al.	2020-03-26
Process for the preparation of nilotinib Grant 9,440,959 - Kompella , et al. September 13, 2	2016-09-13
Process For The Preparation Of Nilotinib App 20150183762 - Kompella; Amala ; et al.	2015-07-02
Process for the preparation of Nilotinib Grant 9,061,028 - Kompella , et al. June 23, 2	2015-06-23
Acid addition salts of (3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]- -benzamide Grant 8,735,415 - Kompella , et al. May 27, 2	2014-05-27
Process For The Preparation Of Nilotinib App 20130210847 - Kompella; Amala ; et al.	2013-08-15
Process For The Preparation Of Highly Pure Crystalline Imatinib Base App 20130060030 - Kompella; Amalia ; et al.	2013-03-07
Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase Grant 8,183,253 - Kompella , et al. May 22, 2	2012-05-22
Acid Addition Salts Of (3,5-bis Trifluoromethyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]- -benzamide App 20120077833 - KOMPELLA; Amala Kishan ; et al.	2012-03-29
Crystal form of phenylamino pyrimidine derivatives Grant 8,067,422 - Kompella , et al. November 29, 2	2011-11-29
Polymorphic form of imatinib mesylate and a process for its preparation Grant 8,048,883 - Amala , et al. November 1, 2	2011-11-01
Acid Addition Salts Of (3,5-bis Trifluoromethyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]- -benzamide App 20110190328 - Kompella; Amala Kishan ; et al.	2011-08-04
Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylami- no)-phenyl]-benzamide Grant 7,939,541 - Kompella , et al. May 10, 2	2011-05-10
Phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase Grant 7,910,598 - Kompella , et al. March 22, 2	2011-03-22
Crystal Form Of Phenylamino Pyrimidine Derivatives App 20090227611 - Kompella; Amala kishan ; et al.	2009-09-10
Phenylaminopyrimidine Derivatives As Inhibitors Of Bcr-abl Kinase App 20080306100 - KOMPELLA; Amala Kishan ; et al.	2008-12-11
Novel Polymorphic Form Of Imatinib Mesylate And A Process For Its Preparation App 20080255138 - Amala; Kompella ; et al.	2008-10-16
Intermediates And A Process Employing The Intermediates For The Preparation Of (3-trifluoromethylsulfonyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylami- No)-phenyl]-benzamide App 20080249121 - Kompella; Amala Kishan ; et al.	2008-10-09
Novel phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase App 20070232633 - Kompella; Amala kishan ; et al.	2007-10-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.